[1] 万谟彬, WAN Mo-bin. 慢性乙型肝炎抗病毒治疗的药物选择 [J]. 内科理论与实践 2009. [2] 中华医学会肝病学分会、感染病学分会, Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. 慢性乙型肝炎防治指南 [J]. 中华肝脏病杂志 2005. [3] 万谟彬, WAN Mo-bin. 治疗慢性乙型肝炎核苷(酸)类似物的药物选择 [J]. 中国感染与化疗杂志 2007.doi:10.3321/j.issn:1009-7708.2007.01.021 [4] 姚光弼. 慢性病毒性肝炎治疗的策略及实施 [J]. 现代实用医学 2003.doi:10.3969/j.issn.1671-0800.2003.01.002 [5] Delmas Julien, Schorr Olivier, Jamard Catherine, Gibbs Craig, Trepo Christian, Hantz Olivier, Zoulim Fabien. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro. [J]. Antimicrobial Agents and Chemotherapy 2002, 2(2). [6] WERLE LAPOSTOLLE B, BOWDEN S, LOCARNINI S. Persistence of cccDNA during the natural history of chronic hepatitis Band deciline during adefovir dipivoxil therapy [J]. Gastroenterology 2004, 126(03). [7] LOK A S, SNOW A, THIBAULT V. Long-term incidence of Aderovir Dipivoxil(ADV) resistance in chronic hepatitis B(CHB)patients after 144 weeks of therapy [J]. Hepatology 2004, 41(Suppl 1). |